Orexigen Therapeutics, Inc. (Nasdaq: OREX) announced that the Light Study independent Data Monitoring Committee has recently confirmed that sufficient major ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE